MorphoSys AG
ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS
Last updated:
Abstract:
The present disclosure is directed to a combination therapy comprising an anti-CD19 antibody or antibody fragment thereof and gamma delta T-cells (.gamma..delta. T-cells) for use in the treatment of leukemia or lymphoma.
Status:
Application
Type:
Utility
Filling date:
30 Oct 2020
Issue date:
6 May 2021